Abstract
Amplification of fetal DNA in maternal plasma is a new way for non-invasive fetal genotyping in pregnancies at risk for disorders where the presence of a paternal DNA sequence contributes to the risk status of the fetus. We describe the use of a panel of 10 bi-allelic highly polymorphic markers to ascertain the presence and amplification of fetal DNA in case the fetus is negative for the targeted paternal "disease" sequence
Original language | English |
---|---|
Pages (from-to) | 123-129 |
Journal | Annals of the New York Academy of Sciences |
Volume | 1075 |
DOIs | |
Publication status | Published - 2006 |